Miyazu T, Ishida N, Asai Y, Tamura S, Tani S, Yamade M
World J Gastrointest Surg. 2023; 15(6):1224-1231.
PMID: 37405109
PMC: 10315124.
DOI: 10.4240/wjgs.v15.i6.1224.
Singh A, Midha V, Narang V, Kedia S, Mahajan R, Dhoble P
Intest Res. 2022; 21(4):452-459.
PMID: 36453008
PMC: 10626019.
DOI: 10.5217/ir.2022.00087.
Denoth L, Juillerat P, Kremer A, Rogler G, Scharl M, Yilmaz B
Microorganisms. 2021; 9(8).
PMID: 34442830
PMC: 8399714.
DOI: 10.3390/microorganisms9081752.
Ostadmohammadi S, Azimirad M, Houri H, Naseri K, Javanmard E, Mirjalali H
Mol Biol Rep. 2021; 48(7):5519-5529.
PMID: 34304365
DOI: 10.1007/s11033-021-06567-8.
Wang M, Mousa O, Friton J, Raffals L, Leighton J, Pasha S
Inflamm Bowel Dis. 2019; 26(5):774-779.
PMID: 31626701
PMC: 7534392.
DOI: 10.1093/ibd/izz209.
The Role of Genetic Factors in Characterizing Extra-Intestinal Manifestations in Crohn's Disease Patients: Are Bayesian Machine Learning Methods Improving Outcome Predictions?.
Bottigliengo D, Berchialla P, Lanera C, Azzolina D, Lorenzoni G, Martinato M
J Clin Med. 2019; 8(6).
PMID: 31212952
PMC: 6617350.
DOI: 10.3390/jcm8060865.
The difference in extraintestinal manifestations of inflammatory bowel disease for children and adults.
Jang H, Kang B, Choe B
Transl Pediatr. 2019; 8(1):4-15.
PMID: 30881893
PMC: 6382501.
DOI: 10.21037/tp.2019.01.06.
Primary Sclerosing Cholangitis, Part 2: Cancer Risk, Prevention, and Surveillance.
Tabibian J, Ali A, Lindor K
Gastroenterol Hepatol (N Y). 2018; 14(7):427-432.
PMID: 30166959
PMC: 6111497.
Primary Sclerosing Cholangitis, Part 1: Epidemiology, Etiopathogenesis, Clinical Features, and Treatment.
Tabibian J, Ali A, Lindor K
Gastroenterol Hepatol (N Y). 2018; 14(5):293-304.
PMID: 29991937
PMC: 6034608.
Ulcerative Colitis with and without Primary Sclerosing Cholangitis: Two Different Diseases?.
Tanaka A, Mertens J
Inflamm Intest Dis. 2018; 1(1):9-14.
PMID: 29922654
PMC: 5988107.
DOI: 10.1159/000445259.
In-patient outcomes of Hematopoietic Stem Cell Transplantation in Patients with Immune Mediated Inflammatory Diseases: A Nationwide Study.
Mehta K, Jaiswal P, Briggs F, Faubion W, Tabibian J, Cominelli F
Sci Rep. 2018; 8(1):6825.
PMID: 29717163
PMC: 5931606.
DOI: 10.1038/s41598-018-24060-4.
Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review.
Fousekis F, Theopistos V, Katsanos K, Tsianos E, Christodoulou D
Gastroenterology Res. 2018; 11(2):83-94.
PMID: 29707074
PMC: 5916631.
DOI: 10.14740/gr990w.
MR elastography in primary sclerosing cholangitis: correlating liver stiffness with bile duct strictures and parenchymal changes.
Bookwalter C, Venkatesh S, Eaton J, Smyrk T, Ehman R
Abdom Radiol (NY). 2018; 43(12):3260-3270.
PMID: 29626258
PMC: 6731546.
DOI: 10.1007/s00261-018-1590-4.
The IBD and PSC Phenotypes of PSC-IBD.
Ricciuto A, Kamath B, Griffiths A
Curr Gastroenterol Rep. 2018; 20(4):16.
PMID: 29594739
DOI: 10.1007/s11894-018-0620-2.
Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.
Mouchli M, Singh S, Boardman L, Bruining D, Lightner A, Rosen C
Inflamm Bowel Dis. 2018; 24(5):1074-1081.
PMID: 29522202
PMC: 6085995.
DOI: 10.1093/ibd/izx096.
Evolving strategies to reduce colectomy rates in primary sclerosing cholangitis-inflammatory bowel disease: clinical remission of corticosteroid refractory colitis post-liver transplant with vedolizumab.
Mumtaz S, Goh J, Hirschfield G, Ferguson J, Cooper S
Frontline Gastroenterol. 2017; 7(4):271-274.
PMID: 28839868
PMC: 5369500.
DOI: 10.1136/flgastro-2016-100711.
Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon.
Krugliak Cleveland N, Rubin D, Hart J, Weber C, Meckel K, Tran A
Clin Gastroenterol Hepatol. 2017; 16(1):68-74.
PMID: 28756053
PMC: 5735030.
DOI: 10.1016/j.cgh.2017.07.023.
Pathogenesis and clinical spectrum of primary sclerosing cholangitis.
Gidwaney N, Pawa S, Das K
World J Gastroenterol. 2017; 23(14):2459-2469.
PMID: 28465630
PMC: 5394509.
DOI: 10.3748/wjg.v23.i14.2459.
Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features.
Palmela C, Peerani F, Castaneda D, Torres J, Itzkowitz S
Gut Liver. 2017; 12(1):17-29.
PMID: 28376583
PMC: 5753680.
DOI: 10.5009/gnl16510.
Risk factors for developing colorectal cancer in Japanese patients with ulcerative colitis: a retrospective observational study-CAPITAL (Cohort and Practice for IBD total management in Kyoto-Shiga Links) study I.
Yoshino T, Nakase H, Takagi T, Bamba S, Okuyama Y, Kawamura T
BMJ Open Gastroenterol. 2016; 3(1):e000122.
PMID: 27933204
PMC: 5128829.
DOI: 10.1136/bmjgast-2016-000122.